Localization of multidrug transporter substrates within model membranes

Area of Science:

• Biochemistry
• Molecular Biology
• Membrane Biophysics

Background:

• Multidrug resistance is a major challenge in medicine, often mediated by cellular efflux pumps.
• P-glycoprotein (PGP) is a key human efflux pump with broad substrate specificity, contributing significantly to multidrug resistance.
• Understanding how PGP interacts with its diverse substrates within cell membranes is crucial for developing strategies to overcome resistance.

Purpose of the Study:

• To systematically investigate the membrane location of various PGP substrates and modulators.
• To elucidate the interaction of these molecules with model lipid membranes.
• To provide insights into the binding site of PGP substrates and modulators.

Main Methods:

• Utilized 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) as a model membrane system.
• Employed 1H NOESY MAS NMR spectroscopy to determine molecular locations.
• Analyzed 1H-1H cross-peaks between substrate/modulator aromatic signals and lipid resonances.

Main Results:

• All seven tested PGP substrates (phenazine, doxorubicin, cephalexin, ampicillin, chloramphenicol, penicillin G, quercetin) and two modulators (quinidine, nicardipine) were localized within the DMPC model membrane.
• The highest concentration of these molecules was consistently found in the region between the lipid phosphate headgroups and the upper hydrocarbon chains.
• This membrane interface region appears to be a preferred location for these diverse PGP-interacting compounds.

Conclusions:

• The study confirms that PGP substrates and modulators interact with the membrane at a specific interface region.
• Findings support the hypothesis that PGP binds its diverse substrates and modulators at or near the membrane surface.
• This understanding of molecular location is vital for future drug design and resistance modulation strategies.